Clinical Trial Update: A Study of LY2624803 in Participants With Transient Insomnia [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating LY2624803 in participants with transient insomnia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transient Insomnia

Drugs mentioned

• LY2624803 (LY2624803)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Transient Insomnia | Phase 1 | Status: COMPLETED